Published in Ultrasound Obstet Gynecol on November 01, 2008
Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. (PROVAS) | NCT02174328
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med (2011) 1.13
Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med (2011) 1.07
Prediction and prevention of hypertensive disorders of pregnancy. Hypertens Res (2016) 1.04
Disentangling prenatal and postnatal maternal genetic effects reveals persistent prenatal effects on offspring growth in mice. Genetics (2011) 0.98
Early prediction of preeclampsia. Obstet Gynecol Int (2014) 0.95
Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS One (2013) 0.91
Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol (2014) 0.89
Midpregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol (2010) 0.89
Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol (2010) 0.88
Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort. BMC Pregnancy Childbirth (2013) 0.88
Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med (2010) 0.83
Early detection of maternal risk for preeclampsia. ISRN Obstet Gynecol (2012) 0.81
Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis. Int J Mol Sci (2015) 0.81
Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control (2016) 0.79
Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth (2015) 0.78
Development and validation of a risk factor scoring system for first-trimester prediction of preeclampsia. Am J Perinatol (2014) 0.77
First trimester serum markers to predict preeclampsia. Wien Med Wochenschr (2012) 0.77
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia. BMC Pregnancy Childbirth (2013) 0.76
Intraplacental villous artery resistance indices and identification of placenta-mediated diseases. J Perinatol (2015) 0.75
First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study. BMC Pregnancy Childbirth (2016) 0.75
A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy. BMC Pregnancy Childbirth (2012) 0.75
Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birth. PLoS One (2017) 0.75
The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLoS One (2017) 0.75
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol (2003) 3.75
Quantification of cervical elastography: a reproducibility study. Ultrasound Obstet Gynecol (2012) 3.15
Ultrasound-guided sampling of umbilical cord and placental blood to assess fetal wellbeing. Lancet (1986) 2.72
The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol (1984) 2.28
Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol (2003) 2.20
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG (2014) 2.20
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol (2013) 2.16
Early ultrasound diagnosis and follow-up of molar pregnancies. Ultrasound Obstet Gynecol (1997) 2.10
Down's syndrome screening in the UK. Lancet (1996) 2.02
Fetal right ventricular contraction and relaxation times at 11-13 weeks' gestation on speckle tracking imaging. Ultrasound Obstet Gynecol (2014) 2.00
Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol (2001) 2.00
Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.99
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol (2015) 1.96
Prenatal diagnosis of a red-cell enzymopathy: triose phosphate isomerase deficiency. Lancet (1989) 1.94
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol (1995) 1.93
Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol (1998) 1.90
International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Investig (1996) 1.87
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol (2012) 1.83
Are all infants of diabetic mothers "macrosomic"? BMJ (1988) 1.81
Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol (1996) 1.79
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (1999) 1.79
Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78
First-trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol (1999) 1.71
Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses. Am J Obstet Gynecol (1990) 1.69
Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol (1987) 1.68
Color Doppler imaging of the uterine artery in pregnancy: normal ranges of impedance to blood flow, mean velocity and volume of flow. Ultrasound Obstet Gynecol (1992) 1.63
Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol (2013) 1.61
Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res Ed) (1987) 1.60
Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol (2001) 1.56
Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obstet Gynecol (2008) 1.56
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol (1999) 1.55
Labor: an immunologically beneficial process for the neonate. Am J Obstet Gynecol (1994) 1.54
Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol (2003) 1.54
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol (2014) 1.53
Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol (2001) 1.50
Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynecol (1992) 1.50
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ (1999) 1.50
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (2008) 1.49
Inter-arm blood pressure differences in pregnant women. BJOG (2008) 1.47
Fetal immunological and haematological changes in intrauterine infection. Br J Obstet Gynaecol (1994) 1.47
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management. J Matern Fetal Neonatal Med (2002) 1.46
Hematologic profile of neonates with growth restriction is associated with rate and degree of prenatal Doppler deterioration. Ultrasound Obstet Gynecol (2012) 1.43
Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases. Am J Obstet Gynecol (1994) 1.43
Have Liley charts outlived their usefulness? Am J Obstet Gynecol (1986) 1.42
Ventilatory requirements for respiratory distress syndrome in small-for-gestational-age infants. Eur J Pediatr (1992) 1.41
Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol (1997) 1.41
First-trimester markers of aneuploidy in women positive for HIV. BJOG (2010) 1.41
Doppler study of the fetal circulation during long-term maternal hyperoxygenation for severe early onset intrauterine growth retardation. Ultrasound Obstet Gynecol (1991) 1.41
Middle cerebral artery flow velocity waveforms in fetal hypoxaemia. Br J Obstet Gynaecol (1990) 1.40
The role of trophoblast dysfunction in the aetiology of miscarriage. Br J Obstet Gynaecol (1993) 1.40
Choroid plexus cysts and chromosomal defects. Br J Radiol (1990) 1.40
Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation. Br J Haematol (1994) 1.40
Perinatal features associated with placental mesenchymal dysplasia. Placenta (1997) 1.40
Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol (2015) 1.39
Early diagnosis of chronic fetal hypoxia in a diabetic pregnancy. Br Med J (Clin Res Ed) (1988) 1.39
Morbidity in infants with antenatally-diagnosed anterior abdominal wall defects. Pediatr Surg Int (2000) 1.39
The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact? Ultrasound Obstet Gynecol (2007) 1.39
Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol (2001) 1.38
Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.38
Clinical significance of first-trimester chorionic bumps: a matched case-control study. Ultrasound Obstet Gynecol (2013) 1.38
Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol (2015) 1.38
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency. Br J Obstet Gynaecol (1996) 1.37
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.37
Ultrasound screening for anencephaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol (1997) 1.37
Development of a training model for ultrasound-guided invasive procedures in fetal medicine. Ultrasound Obstet Gynecol (1995) 1.36
Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol (2001) 1.35
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther (2014) 1.33
Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet (1986) 1.32
Expectant management of missed miscarriage. Br J Obstet Gynaecol (1998) 1.32
Intrapartum sonography to determine fetal head position. J Matern Fetal Neonatal Med (2002) 1.29
The femoral head/neck offset and hip resurfacing. J Bone Joint Surg Br (2007) 1.29
Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther (1986) 1.28
Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol (1990) 1.27
Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.27
Plasma insulin in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.27
Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med (2002) 1.26
Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol (1999) 1.25
Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol (2011) 1.25
One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol (2000) 1.24
Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol (1998) 1.24
Maternal oxygen therapy for intrauterine growth retardation. Lancet (1987) 1.22
The prevalence of non-viable pregnancy at 10-13 weeks of gestation. Ultrasound Obstet Gynecol (1996) 1.22
Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol (2007) 1.20
Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy. J Clin Pathol (1985) 1.19
Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol (1994) 1.19
Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history. Ultrasound Obstet Gynecol (1998) 1.18
Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension (2001) 1.18
Endoscopic laser coagulation of umbilical cord vessels in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol (1994) 1.17
Lung and heart volumes by three-dimensional ultrasound in normal fetuses at 12-32 weeks' gestation. Ultrasound Obstet Gynecol (2006) 1.17
Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol (2007) 1.16
Rapid karyotyping in non-lethal fetal malformations. Lancet (1986) 1.16
A single-operator technique for first-trimester chorion biopsy. Lancet (1983) 1.16
A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol (2008) 1.16
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol (2012) 1.15
Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix. Ultrasound Obstet Gynecol (1998) 1.14
Comparison of transvaginal digital examination with intrapartum sonography to determine fetal head position before instrumental delivery. Ultrasound Obstet Gynecol (2003) 1.13
Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol (2009) 1.13